A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway
Martin Fried, Karin Dolezalova, Adam P Chambers, Elliott J Fegelman, Robin Scamuffa, Michael L Schwiers, Jason R Waggoner, Martin Haluzik, Randy J Seeley, Martin Fried, Karin Dolezalova, Adam P Chambers, Elliott J Fegelman, Robin Scamuffa, Michael L Schwiers, Jason R Waggoner, Martin Haluzik, Randy J Seeley
Abstract
Objective: To explore partial jejunal diversion (PJD) via a side-to-side jejuno-jejunostomy for improved glycemic control in type 2 diabetes mellitus (T2DM). PJD is an anatomy-sparing, technically simple surgery in comparison to the predominate metabolic procedures, Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). Positive results in a rodent model prompted a human proof-of-concept study.
Research design and methods: Pre-clinically, 71 rats were studied in a model of metabolic dysfunction induced by a high-fat diet; 33 animals undergoing one of two lengths of PJD were compared with 18 undergoing sham, 10 RYGB and 10 jejuno-ileal bypass. Clinically, 15 adult subjects with treated but inadequately controlled T2DM (hemoglobin A1c (HbA1c) of 8.0%-11.0%), body mass index of 27.0-40.0 kg/m2, and C peptide ≥3 ng/mL were studied. Follow-up was at 2 weeks, and 3, 6, 9, and 12 months post-PJD.
Results: Pre-clinically, positive impacts with PJD on glucose homeostasis, cholesterol, and body composition versus sham control were demonstrated. Clinically, PJD was performed successfully without serious complications. Twelve months post-surgery, the mean (SD) reduction from baseline in HbA1c was 2.3% (1.3) (p<0.01).
Conclusions: PJD may provide an anatomy sparing, low-risk, intervention for poorly controlled T2DM without significant alteration of the patient's lifestyle. The proof-of-concept study is limited by a small sample size and advanced disease, with 80% of participants on insulin and a mean time since diagnosis of over 10 years. Further study is warranted.
Trial registration number: NCT02283632; Pre-results.
Keywords: Metabolic; Surgery; Type 2 Diabetes.
Conflict of interest statement
Competing interests: MF, KD, APC, and MH have nothing to declare. RJS currently receives funding from Ethicon, Inc. EJF, RS, MLS, and JRW are employed by Ethicon, Inc.
Figures
References
- Global Report on Diabetes. World Health Organization; (accessed Mar 2017).
- Global Health Estimates 2015. Deaths by Cause, Age, Sex, by Country and by Region, 2000-2015. Geneva: World Health Organization, 2016. (accessed Mar 2017).
- Schauer PR, Bhatt DL, Kirwan JP, et al. . Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N Engl J Med 2014;370:2002–13. 10.1056/NEJMoa1401329
- Rubino F, Nathan DM, Eckel RH, et al. . Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for Type 2 diabetes: A joint statement by International Diabetes Organizations. Diabetes Care 2016;39:861–77.
- Stark Casagrande S, Fradkin JE, Saydah SH, et al. . The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 2013;36:2271–9. 10.2337/dc12-2258
- Schauer PR, Bhatt DL, Kirwan JP, et al. . Bariatric surgery versus intensive medical therapy for diabetes - 5-Year outcomes. N Engl J Med 2017;376:641–51. 10.1056/NEJMoa1600869
- Rubino F, Schauer PR, Kaplan LM, et al. . Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010;61:393–411. 10.1146/annurev.med.051308.105148
- Singh D, Laya AS, Clarkston WK, et al. . Jejunoileal bypass: a surgery of the past and a review of its complications. World J Gastroenterol 2009;15:2277–9. 10.3748/wjg.15.2277
- Baker MT. The history and evolution of bariatric surgical procedures. Surg Clin North Am 2011;91:1181–201. 10.1016/j.suc.2011.08.002
- Sánchez-Pernaute A, Rubio MÁ, Pérez Aguirre E, et al. . Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in first 100 patients. Surg Obes Relat Dis 2013;9:731–5. 10.1016/j.soard.2012.07.018
- Melissas J, Peppe A, Askoxilakis J, et al. . Sleeve gastrectomy plus side-to-side jejunoileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation. Obes Surg 2012;22:1104–9. 10.1007/s11695-012-0637-9
- Woods SC, Seeley RJ, Rushing PA, et al. . A controlled high-fat diet induces an obese syndrome in rats. J Nutr 2003;133:1081–7.
- Jandacek RJ, Heubi JE, Tso P. A novel, noninvasive method for the measurement of intestinal fat absorption. Gastroenterology 2004;127:139–44. 10.1053/j.gastro.2004.04.007
- Chambers AP, Jessen L, Ryan KK, et al. . Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 2011;141:950–8. 10.1053/j.gastro.2011.05.050
- Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–70. 10.2337/diacare.22.9.1462
- Herzberg-Schäfer SA, Staiger H, Heni M, et al. . Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function. PLoS One 2010;5:e14194 10.1371/journal.pone.0014194
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–13.
- Stemmer K, Bielohuby M, Grayson BE, et al. . Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology 2013;154:2015–24. 10.1210/en.2012-2130
- Aminian A, Brethauer SA, Kirwan JP, et al. . How safe is metabolic/diabetes surgery? Diabetes Obes Metab 2015;17:198–201. 10.1111/dom.12405
- Gummesson A, Nyman E, Knutsson M, et al. . Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes. Diabetes Obes Metab 2017:1–11. 10.1111/dom.12971
- Melissas J, ErenTaskin H, Peirasmakis D, et al. . A Simple food-diverting operation for Type 2 diabetes treatment. Preliminary results in humans with BMI 28-32 kg/m(2). Obes Surg 2017;27:22–9. 10.1007/s11695-016-2251-8
- Dixon JB, Zimmet P, Alberti KG, et al. . Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011;28:628–42. 10.1111/j.1464-5491.2011.03306.x
Source: PubMed